ChargePoint
ChargePoint Technology has launched a containment valve that addresses the issue of containment differently to the company’s other patented split butterfly valves.
ChargePoint PharmaSafe pro has been specifically developed to meet the demands for operator protection against increasingly potent ingredients by providing a containment performance of <1 µg/m³/OEB5. It achieves this high level of performance by utilising a simple extraction process, which is integral to the valve, to minimise the volume of airborne contamination when the valve is separated, post transfer. The extraction system requirement is designed so that customers can utilise existing onsite supply.
This valve, along with ChargePoint AseptiSafe aseptic transfer valves, will be showcased at INTERPHEX.
Booth 2462, INTERPHEX 2014, 18–20 March 2014, Javits Center in New York City, US.
ChargePoint Technology Ltd, +44 151 728 45000, sales@thechargepoint.com, www.thechargepoint.com.